Paragon Capital Management LTD Merck & Co., Inc. Transaction History

Paragon Capital Management LTD

$487 Million
Q3 2024

A detailed history of Paragon Capital Management LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Paragon Capital Management LTD holds 4,283 shares of MRK stock, worth $436,352. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,283

Previous 4,275 0.19%

Holding current value

$436,352

Previous $529,000 8.13%

% of portfolio

0.1%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$111.15 - $128.97 $889 - $1,031	8 Added 0.19%	4,283 $486,000
Q2 2024 Jul 12, 2024	SELL	$123.8 - $132.96 $70,689 - $75,920	-571 Reduced 11.78%	4,275 $529,000
Q1 2024 Apr 11, 2024	BUY	$113.24 - $131.95 $905 - $1,055	8 Added 0.17%	4,846 $639,000
Q4 2023 Jan 12, 2024	BUY	$100.18 - $109.02 $801 - $872	8 Added 0.17%	4,838 $527,000
Q3 2023 Oct 10, 2023	BUY	$102.95 - $114.33 $617 - $685	6 Added 0.12%	4,830 $497,000
Q2 2023 Jul 11, 2023	SELL	$108.61 - $118.38 $4,887 - $5,327	-45 Reduced 0.92%	4,824 $556,000
Q1 2023 Apr 13, 2023	BUY	$102.94 - $114.86 $514 - $574	5 Added 0.1%	4,869 $518,000
Q4 2022 Jan 17, 2023	BUY	$87.44 - $112.11 $524 - $672	6 Added 0.12%	4,864 $0
Q3 2022 Oct 14, 2022	BUY	$84.53 - $94.96 $507 - $569	6 Added 0.12%	4,858 $418,000
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $232,603 - $263,667	-2,786 Reduced 36.48%	4,852 $442,000
Q1 2022 Apr 19, 2022	BUY	$73.51 - $82.4 $7,277 - $8,157	99 Added 1.31%	7,638 $627,000
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $1,807 - $2,263	-25 Reduced 0.33%	7,539 $578,000
Q3 2021 Oct 19, 2021	SELL	$71.68 - $78.83 $26,091 - $28,694	-364 Reduced 4.59%	7,564 $568,000
Q2 2021 Jul 29, 2021	BUY	$70.31 - $77.77 $127,190 - $140,685	1,809 Added 29.56%	7,928 $617,000
Q1 2021 Apr 21, 2021	BUY	$68.86 - $81.11 $413 - $486	6 Added 0.1%	6,119 $472,000
Q4 2020 Jan 26, 2021	BUY	$71.77 - $79.65 $430 - $477	6 Added 0.1%	6,113 $500,000
Q3 2020 Oct 22, 2020	BUY	$73.18 - $82.95 $446,910 - $506,575	6,107 New	6,107 $507,000
Q1 2020 Apr 29, 2020	SELL	$63.36 - $87.82 $411,206 - $569,951	-6,490 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $387 - $437	5 Added 0.08%	6,490 $590,000
Q3 2019 Oct 18, 2019	SELL	$76.08 - $82.93 $41,920 - $45,694	-551 Reduced 7.83%	6,485 $546,000
Q2 2019 Jul 23, 2019	BUY	$69.84 - $81.59 $349 - $407	5 Added 0.07%	7,036 $590,000
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $20,526 - $23,411	-295 Reduced 4.03%	7,031 $585,000
Q4 2018 Jan 29, 2019	BUY	$65.24 - $75.71 $65 - $75	1 Added 0.01%	7,326 $560,000
Q3 2018 Nov 05, 2018	SELL	$57.69 - $67.84 $25,614 - $30,120	-444 Reduced 5.72%	7,325 $520,000
Q2 2018 Aug 21, 2018	BUY	$50.83 - $59.72 $50 - $59	1 Added 0.01%	7,769 $472,000
Q1 2018 Apr 24, 2018	BUY	$50.96 - $59.23 $395,857 - $460,098	7,768 New	7,768 $423,000
Q4 2017 Jan 29, 2018	SELL	$51.62 - $61.64 $442,331 - $528,193	-8,569 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $502,743 - $540,960	8,569	8,569 $549,000

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.

Account

Paragon Capital Management LTD Merck & Co., Inc. Transaction History